V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010103 | 270005932 | 1.63 | null | Palliative (P) | 2014-01-24 | 2014-01-27 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270023050 | ECHELON 1 TRIAL |
| 270010105 | 270012930 | null | 71.6 | null | 2016-05-01 | 2016-05-13 | Vinblastine | N | N | 270023068 | BRENTUXIMAB |
| 270010106 | 270005934 | null | null | Not known (9) | 2014-03-31 | 2014-04-06 | Brentuximab Vedotin | 02 | N | 270023071 | ABVD R |
| 270010107 | 270005934 | null | 75.3 | Palliative (P) | 2017-12-14 | 2017-12-27 | Rituximab | N | N | 270023071 | BEVACIZUMAB |
| 270010108 | 270005934 | null | 109 | null | 2013-06-17 | 2013-06-30 | CVP R | 99 | null | 270023071 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010109 | 270005935 | 1.73 | null | Disease modification (D) | 2017-08-05 | 2017-08-17 | Vinblastine | N | null | 270023082 | BENDAMUSTINE + RITUXIMAB |
| 270010112 | 270017873 | 1.73 | 63 | Disease modification (D) | 2018-10-21 | 2018-10-30 | MYELOMA XI TRIAL | 02 | N | 270023120 | BEAM + FLUDARABINE |
| 270010113 | 270017873 | 1.75 | 84.5 | Curative (C) | 2017-11-07 | 2017-11-13 | CISPLATIN + GEMCITABINE | N | N | 270023120 | NOT MATCHED |
| 270010114 | 270017873 | null | 72.1 | Curative (C) | 2015-08-24 | 2015-08-25 | Vinblastine | null | Y | 270023120 | RITUXIMAB |
| 270010115 | 270019824 | 1.22 | 90.1 | Palliative (P) | 2013-09-25 | 2013-09-29 | Chlorambucil | 02 | N | 270023128 | VINBLASTINE |
| 270010116 | 270005936 | 1.68 | 54 | Disease modification (D) | 2014-08-03 | 2014-08-16 | CVP R | N | Y | 270023130 | ESHAP |
| 270010117 | 270005936 | 1.67 | 102 | null | 2017-05-31 | 2017-05-31 | R GCVP | 02 | N | 270023130 | CVP R |
| 270010118 | 270005936 | null | 78.3 | Curative (C) | 2015-07-06 | 2015-08-02 | CVP R | 02 | N | 270023130 | ESHAP |
| 270010119 | 270017874 | null | 71.6 | Neo-adjuvant (N) | null | 2016-05-12 | ECHELON 1 TRIAL | null | null | 270023158 | CARBOPLATIN |
| 270010120 | 270005937 | 1.75 | 80.9 | null | 2015-06-16 | 2015-06-16 | CVP R | N | N | 270023165 | GEMCITABINE + VINORELBINE |
| 270010121 | 270005938 | null | 46 | Curative (C) | 2016-11-05 | 2016-12-04 | PACIFICO TRIAL | null | Y | 270023166 | CVP R |
| 270010122 | 270005939 | null | 0 | Curative (C) | 2014-04-05 | 2014-04-16 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | 270023172 | NOT MATCHED |
| 270010124 | 270005941 | 1.64 | 82 | Curative (C) | 2014-09-21 | 2014-09-28 | Rituximab | 99 | null | 270023185 | MITOMYCIN INTRAVESICULAR |
| 270010125 | 270005941 | 1.7 | 74.3 | Curative (C) | 2017-03-20 | 2017-04-04 | IBRUTINIB | N | y | 270023185 | CVP R |
| 270010126 | 270005942 | 1.8 | 40 | null | 2016-01-11 | 2016-01-20 | BREVITY TRIAL | 02 | N | 270023195 | LOPP |
| 270010127 | 270005942 | 1.58 | 112.8 | Disease modification (D) | 2017-09-26 | 2017-09-26 | Bevacizumab+Carbo+Gemcitabine | 02 | null | 270023195 | CHOP |
| 270010128 | 270005942 | null | null | null | 2015-03-07 | 2015-03-30 | Rituximab | null | null | 270023195 | PMITCEBOM |
| 270010129 | 270005943 | 1.57 | 59 | Curative (C) | 2016-08-04 | 2016-08-25 | Rituximab | N | N | 270023203 | CHOP |
| 270010130 | 270005943 | null | null | null | 2016-09-08 | 2016-09-11 | ECHELON 1 TRIAL | N | N | 270023203 | FEC |
| 270010131 | 270005943 | 1.55 | 0 | null | 2017-10-29 | 2017-10-29 | Carboplatin + Pemetrexed | 02 | N | 270023203 | HYDROXYCARBAMIDE |
| 270010132 | 270017875 | 1.9 | 96.5 | Curative (C) | 2016-12-12 | 2016-12-25 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | Y | 270023207 | ECHELON-1 TRIAL |
| 270010133 | 270005944 | 1.52 | 52 | Curative (C) | 2015-11-21 | 2015-12-07 | null | N | N | 270023212 | CVP R |
| 270010134 | 270005945 | 1.54 | 53.1 | Disease modification (D) | 2016-01-23 | 2016-03-18 | ECHELON 1 TRIAL | 02 | N | 270023218 | VINBLASTINE |
| 270010135 | 270012937 | null | 29.35 | null | null | 2014-05-05 | Brentuximab Vedotin | null | null | 270023219 | CHLORAMBUCIL |
| 270010136 | 270012937 | 1.83 | 48 | Curative (C) | null | 2017-05-22 | null | null | null | 270023219 | RITUXIMAB |
| 270010137 | 270005946 | 1.79 | 73.3 | Palliative (P) | 2016-02-16 | 2016-02-22 | BREVITY TRIAL | 2 | null | 270023239 | PEMETREXED |
| 270010138 | 270005947 | 1.66 | null | Curative (C) | null | 2014-01-07 | CVP | null | null | 270023251 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 270010139 | 270012938 | null | 65 | Curative (C) | 2017-07-29 | 2017-07-29 | FEC | 2 | N | 270023261 | RITUXIMAB |
| 270010140 | 270012938 | 1.8 | 90.9 | Curative (C) | 2015-09-28 | 2015-10-27 | CVP R | 02 | N | 270023261 | NOT MATCHED |
| 270010141 | 270005948 | 1.65 | null | Curative (C) | 2015-11-26 | 2015-12-07 | IVE | 02 | Y | 270023286 | CVP R |
| 270010142 | 270005949 | null | null | Palliative (P) | 2017-04-04 | 2017-05-23 | Hydroxycarbamide | N | Y | 270023289 | AZACITIDINE |
| 270010143 | 270005950 | 1.65 | 86 | Curative (C) | 2016-11-07 | 2016-11-08 | ECHELON 1 TRIAL | 02 | N | 270023297 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010144 | 270005951 | 1.68 | 58.2 | null | 2015-04-29 | 2015-04-30 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270023299 | CVP R |
| 270010145 | 270005952 | 1.76 | 44.2 | Curative (C) | 2017-09-27 | 2017-09-30 | BREVITY TRIAL | 02 | N | 270023300 | ECHELON 1 TRIAL |
| 270010146 | 270005953 | null | 90 | Palliative (P) | 2017-02-12 | 2017-02-15 | CHOP | 99 | null | 270023301 | CHLVPP/EVA |
| 270010147 | 270005953 | null | 69 | Curative (C) | 2013-08-26 | 2013-09-08 | ESHAP | null | N | 270023301 | MYELOMA XI TRIAL |
| 270010148 | 270005953 | 1.87 | null | Palliative (P) | 2016-09-14 | 2016-09-16 | NIVOLUMAB | 2 | Y | 270023301 | HYDROXYCARBAMIDE |
| 270010149 | 270005954 | 1.72 | 94.7 | Curative (C) | 2016-06-25 | 2016-07-08 | ETOPOSIDE | N | N | 270023327 | CVP R |
| 270010150 | 270005955 | 1.56 | 48.7 | Palliative (P) | null | 2016-10-09 | LOPP | 99 | null | 270023330 | LOPP |
| 270010151 | 270005955 | 1.6 | 64.2 | Curative (C) | 2016-03-30 | 2016-03-30 | Rituximab | Y | N | 270023330 | MITOMYCIN INTRAVESICULAR |
| 270010152 | 270005956 | 1.8 | 87 | Curative (C) | 2018-02-05 | 2018-03-12 | Vinblastine | 2 | N | 270023335 | DHAP |
| 270010153 | 270012941 | 1.82 | 78.6 | Curative (C) | 2016-09-28 | 2016-10-03 | R GCVP | N | N | 270023336 | CVP |
| 270010154 | 270012941 | 1.57 | 83.5 | Palliative (P) | 2017-07-27 | 2017-07-29 | Rituximab | 02 | N | 270023336 | GEMCITABINE + OXALIPLATIN |
| 270010155 | 270012941 | 1.84 | 102.5 | Curative (C) | 2016-08-27 | 2016-08-27 | ChIVPP/EVA | N | N | 270023336 | PREDNISOLONE + VINBLASTINE + RITUXIMAB |
| 270010156 | 270005957 | 1.64 | 86 | Curative (C) | 2017-08-04 | 2017-08-05 | AXITINIB | 02 | N | 270023357 | NOT MATCHED |